Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

CNRS and collaborators patent acetylcholinesterase reactivators

April 1, 2022

Red Bull GmbH presents dopamine reuptake inhibitors

Jan. 20, 2022

Metabotropic glutamate mGlu2 receptor found to be associated with alcoholism

Nov. 30, 2021

Researchers develop a rat model of oxycodone/cocaine withdrawal syndrome

Nov. 23, 2021

One-year challenge data from preclinical study of ATI-1701 in lethal model of tularemia

Nov. 22, 2021

New and known compounds targeting PTPRD may treat AD, addiction and restless legs syndrome

Nov. 4, 2021

New treatment targets identified in opiate abstinence

Nov. 3, 2021

RM-1490, a novel MOR agonist as maintenance therapeutic in opioid use disorder

Nov. 2, 2021

Aileron Therapeutics' ALRN-6924 shows preclinical activity against acute radiation injury

Oct. 8, 2021

New 5-HT2 receptor agonists identified

Oct. 6, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...